-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Taysha Gene Therapies, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
- Taysha Gene Therapies, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.33M, a 50% increase year-over-year.
- Taysha Gene Therapies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $10.5M, a 15.5% decline year-over-year.
- Taysha Gene Therapies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.91M, a 56.2% decline from 2022.
- Taysha Gene Therapies, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $18M, a 0.78% decline from 2021.
- Taysha Gene Therapies, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $18.2M, a 442% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)